Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: -

Danske Invest MediLife Fund

+ Add to Watchlist

MANMEDT:FH

860.64 EUR 0.000.00%

As of 01:59:30 ET on 03/30/2015.

Snapshot for Danske Invest MediLife Fund (MANMEDT)

Year To Date: +21.21% 3-Month: +20.79% 3-Year: +27.71% 52-Week Range: 510.24 - 924.41
1-Month: +3.01% 1-Year: +53.39% 5-Year: +17.89% Beta vs MXWO0PB: 1.04

Mutual Fund Chart for MANMEDT

No chart data available.
  • MANMEDT:FH 860.64
  • 1M
  • 1Y
Interactive MANMEDT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for MANMEDT

Danske Invest MediLife is an open-end fund registered in Finland. The Fund invests in pharmaceutical, biotechnology and medical technology and equipment companies worldwide. The Fund offers potential high yield, but also above average risk. The Fund's aim is to exceed the performance of the MSCI Pharmaceuticals -index \in the long term.

Inception Date: 08-15-2000 Telephone: 358-10-236-10
Managers: -
Web Site: www.danskeinvest.fi

Fundamentals for MANMEDT

NAV (on 2015-03-30) 860.64
Assets (M) (on 2015-02-28) 83.54
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 500.00

Dividends for MANMEDT

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-04-02) 0.02
Dividend Yield (ttm) 0.00

Fees & Expenses for MANMEDT

Front Load 1.00
Back Load 1.00
Current Mgmt Fee 1.95
Redemption Fee 1.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for MANMEDT

Filing Date: 12/31/2014
Name Position Value % of Total
Actavis plc 14,779 3,130,050 4.927%
Mallinckrodt PLC 34,960 2,848,518 4.483%
Johnson & Johnson 29,340 2,524,341 3.973%
Vertex Pharmaceuticals Inc 24,703 2,414,610 3.800%
Celgene Corp 26,070 2,399,367 3.776%
Roche Holding AG 10,650 2,390,780 3.763%
Merck & Co Inc 45,140 2,109,183 3.320%
Shire PLC 36,425 2,096,990 3.301%
Sanofi 51,675 1,939,194 3.052%
Biogen Inc 6,315 1,763,721 2.776%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil